Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001

By Andersson Michael   Jensen Maj-Britt   Engholm Gerda   Henrik Storm Hans  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 755-764

Informa Healthcare

Access to resources Recommend Favorite

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

By Buchholz Thomas  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 53-55

Informa Healthcare

Access to resources Recommend Favorite

Tamoxifen Added to Adjuvant Chemotherapy in Premenopausal Women with Early Breast Cancer: is it Standard Practice or Still a Subject for Study?

By Bramwell V.H.C.   Pritchard K.I.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1625-1627

Elsevier

Access to resources Recommend Favorite

Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c

By Kyndi M.   Sørensen F. B.   Knudsen H.   Alsner J.   Overgaard M.   Nielsen H. M.   Overgaard J.  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 608-617

Informa Healthcare

Access to resources Recommend Favorite

DBCG: The Danish Breast Cancer Cooperative Group - a 30-year struggle for better breast cancer treatment in Denmark

By Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 491-496

Informa Healthcare

Access to resources Recommend Favorite